Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Современные представления о неалкогольной жировой болезни печени
Н.Н.Голубев, И.Н.Никушкина. Современные представления о неалкогольной жировой болезни печени. Consilium Medicum. Гастроэнтерология (Прил.). 2010; 2: 78-81.
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Полный текст
Список литературы
1. Loria P, Adinolfi LE, Bellentani S et al. Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee. Dig Liver Dis 2010; 42: 272–82.
2. de Alwis NMW, Day CP. Non-alcoholic fatty liver disease: The mist gradually clears. J Hepatol 2008; 48: S104–12.
3. Lazo M, Clark JM. The Epidemiology of Nonalcoholic Fatty Liver Disease: A Global Perspective. Semin Liver Dis 2008; 28: 339–50.
4. Ivashkin V, Drapkina O. The prevalence of non-alcoholic fatty liver disease in Russian Federation. Gut 2009; 58: 1207.
5. Day CP. Natural history of NAFLD: remarkably benign in the absence of cirrhosis. Gastroenterology 2005; 129: 375–8.
6. Ekstedt M, Franzen LE, Mathiesen UL et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006; 44: 865–73.
7. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346: 1221–31.
8. Day CP, James OF. Steatohepatitis: a tale of two «hits»? Gastroenterology 1998; 114: 842–5.
9. Adams LA, Angulo P, Lindor KD. Nonalcoholic fatty liver disease. CMAJ 2005; 172: 899–905.
10. Cheung O, Sanyal AJ. Recent Advances in Nonalcoholic Fatty Live Disease. Curr Opin Gastroenterol 2010; 26: 202–8.
11. Tolman KG, Dalpiaz AS. Treatment of non-alcoholic fatty liver disease. Ther Clin Risk Management 2007; 3: 1153–63.
12. Brunt EM. Pathology of fatty liver disease. Mod Pathol 2007; 20 (Suppl. 1): S40–8.
13. Yoneda M, Fujita K, Inamori M. Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD). Gut 2007; 56: 1330–1.
14. Grattagliano I. Managing nonalcoholic fatty liver disease, recommendations for family physicians. Can Fam Physician 2007; 53: 857–63.
15. Angulo P. NAFLD, obesity, and bariatric surgery. Gastroenterology 2006; 130: 1848–52.
16. Vuppalanchi R, Chalasani N. Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Selected Practical Issues in Their Evaluation and Management. Hepatology 2009; 49: 306–17.
17. Bugianesi E, Gentilcore E, Manini R et al. A randomized controlled trial of metformin versus vitamin E or prescriptive diet in non-alcoholic fatty liver disease. Am J Gastroenterol 2005; 100: 1082–90.
18. Browning J. Statins and hepatic steatosis: perspectives from the Dallas Heart Study. Hepatology 2006; 44: 466–71.
2. de Alwis NMW, Day CP. Non-alcoholic fatty liver disease: The mist gradually clears. J Hepatol 2008; 48: S104–12.
3. Lazo M, Clark JM. The Epidemiology of Nonalcoholic Fatty Liver Disease: A Global Perspective. Semin Liver Dis 2008; 28: 339–50.
4. Ivashkin V, Drapkina O. The prevalence of non-alcoholic fatty liver disease in Russian Federation. Gut 2009; 58: 1207.
5. Day CP. Natural history of NAFLD: remarkably benign in the absence of cirrhosis. Gastroenterology 2005; 129: 375–8.
6. Ekstedt M, Franzen LE, Mathiesen UL et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006; 44: 865–73.
7. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346: 1221–31.
8. Day CP, James OF. Steatohepatitis: a tale of two «hits»? Gastroenterology 1998; 114: 842–5.
9. Adams LA, Angulo P, Lindor KD. Nonalcoholic fatty liver disease. CMAJ 2005; 172: 899–905.
10. Cheung O, Sanyal AJ. Recent Advances in Nonalcoholic Fatty Live Disease. Curr Opin Gastroenterol 2010; 26: 202–8.
11. Tolman KG, Dalpiaz AS. Treatment of non-alcoholic fatty liver disease. Ther Clin Risk Management 2007; 3: 1153–63.
12. Brunt EM. Pathology of fatty liver disease. Mod Pathol 2007; 20 (Suppl. 1): S40–8.
13. Yoneda M, Fujita K, Inamori M. Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD). Gut 2007; 56: 1330–1.
14. Grattagliano I. Managing nonalcoholic fatty liver disease, recommendations for family physicians. Can Fam Physician 2007; 53: 857–63.
15. Angulo P. NAFLD, obesity, and bariatric surgery. Gastroenterology 2006; 130: 1848–52.
16. Vuppalanchi R, Chalasani N. Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Selected Practical Issues in Their Evaluation and Management. Hepatology 2009; 49: 306–17.
17. Bugianesi E, Gentilcore E, Manini R et al. A randomized controlled trial of metformin versus vitamin E or prescriptive diet in non-alcoholic fatty liver disease. Am J Gastroenterol 2005; 100: 1082–90.
18. Browning J. Statins and hepatic steatosis: perspectives from the Dallas Heart Study. Hepatology 2006; 44: 466–71.
Авторы
Н.Н.Голубев, И.Н.Никушкина
Кафедра пропедевтики внутренних болезней и гастроэнтерологии МГМСУ
Кафедра пропедевтики внутренних болезней и гастроэнтерологии МГМСУ
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.